Home » Tenders » Americas » USA » Tender 140554361

Noi to Sole Source to Quva Pharma, Inc Tender in USA - 140554361

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a Noi to Sole Source to Quva Pharma, Inc in the USA. This Tender notice was published on 02 May 2026 and is scheduled to close on 06 May 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 140554361, while the tender notice number is NOI-OD-26-000038 and Registering on the platform.

Procurement Summary

Country: USA

Summary: Noi to Sole Source to Quva Pharma, Inc

Deadline: 06 May 2026

Posting Date: 02 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 140554361

Document Ref. No.: NOI-OD-26-000038

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

The purpose of this acquisition is to purchase 503b compounded Intravenous (IV) Narcotics for patient care. Market research has been conducted with only two responses, from QUVA, the known Compounder and distributor for these IV narcotics. Through trade shows, continuous learning seminars and trade journals, the CC Pharmacy Department stays abreast of the industry and is current on the availability of singular distribution outlets for these medications.
• Product Service Code: 6515 - Medical and Surgical Instruments, Equipment, and Supplies
• NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
• Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA
POTS: 26-000038
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a one-year contract to QuVa Pharma, Inc., located at 3 Sugar Creek Center Boulevard, Sugarland, TX 77478, on a firm fixed price sole source award basis for the purchase of 503b compound Intravenous (IV) Narcotics for patient care.
The proposed vendor, QuVa Pharma Inc., is the Original Manufacturer and has not designated other distributors of IV narcotics in the U.S.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the d...
Notice ID: noi-od-26-000038

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institutes of health olao

Product Service Code: 6515 - medical and surgical instruments, equipment, and supplies

NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Inactive Dates: may 21, 2026

Inactive Policy: 15 days after response date

Documents

Browse More

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By